A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine

Get answers to your Orthopaedic Oncology questions.
Dr. Henock Wolde-Semait’s Bio | Q&A Archive
Tumor - bone; Bone cancer
A bone tumor is an abnormal growth of cells within the bone that may be noncancerous (benign) or cancerous (malignant).
The cause of bone tumors is unknown. They often arise in areas of rapid growth. Possible causes include:
But in most cases no specific cause is found.
Osteochondromas are the most common noncancerous (benign) bone tumors, and occur most often in people between the ages of 10 and 20. Some benign bone tumors go away on their own and do not require treatment. These benign tumors may be monitored periodically by x-ray.
Cancers that start in the bones are referred to as primary bone tumors. Cancers that start in another part of the body (such as the breast, lungs, or colon) are secondary or metastatic bone tumors that behave very differently from primary bone tumors. Multiple myeloma often affects or involves the bone, but is also not considered a primary bone tumor.
Cancerous (malignant) bone tumors include:
The cancers that most often spread to the bone are cancers of the:
These forms of cancer usually affect older people.
Bone cancer was once very common among people who painted radium on watch faces (to produce glow-in-the-dark dials). The painters would "tip" the brush with their tongue (in order to produce fine work) and absorb minute amounts of radium, which deposited in the bone and caused cancer. The practice of using radium paint was abandoned in the middle of the 20th century.
The incidence of bone cancer is higher in families with familial cancer syndromes. The incidence of bone cancer in children is approximately 5 cases per million children each year.
Baker LH. Bone tumors: primary and metastatic bone lesions. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 212.
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Bone Cancer. National Comprehensive Cancer Network; 2010. Version 1.2010.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885